mHealth Insulin Titration and Management (iSage)

mHealth Insulin Titration and Management (iSage)

The purpose of this study is to determine the benefits of using the iSage app for basal insulin titration and support. By doing this study the investigators hope to learn whether the app improves the participant's ability to follow his/her healthcare provider's instructions to adjust his/her insulin doses.

Inclusion Criteria:

• Diagnosed Type 2 Diabetes, based on the World Health Organization (WHO) criteria, treated with basal insulin
• HbA1c 8-11% inclusive
• Glomerular filtration rate (GFR) > 60 ml/min
• Has an Android or iOS based compatible smartphone (iOS 9.0 or above, Android 4.4 or above)
• Willing to perform at least 1 fasting finger stick glucose measurements every morning
• English speaking

Exclusion Criteria:

• Diagnosis of hypoglycemic unawareness
• Diagnosis of hyperglycemic hyperosmolar non-ketotic coma (HONK) or diabetic ketoacidosis (DKA) within 6 months of enrollment
• Recent (within the last 6 months)/current use of non-topical steroids
• Insulin requirements in excess of 1 U/kg per day
• Use of pioglitazone or another thiazolidinedione (TZD)
• In the opinion of the provider, HgbA1c goals should be adjusted above 7% due to infirmity, unstable cardiovascular disease, etc.